Andrew Belfield

538 total citations
10 papers, 339 citations indexed

About

Andrew Belfield is a scholar working on Organic Chemistry, Molecular Biology and Management of Technology and Innovation. According to data from OpenAlex, Andrew Belfield has authored 10 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Management of Technology and Innovation. Recurrent topics in Andrew Belfield's work include Innovative Approaches in Technology and Social Development (3 papers), Catalytic Cross-Coupling Reactions (2 papers) and Asymmetric Hydrogenation and Catalysis (2 papers). Andrew Belfield is often cited by papers focused on Innovative Approaches in Technology and Social Development (3 papers), Catalytic Cross-Coupling Reactions (2 papers) and Asymmetric Hydrogenation and Catalysis (2 papers). Andrew Belfield collaborates with scholars based in United Kingdom, Sweden and Germany. Andrew Belfield's co-authors include Varinder K. Aggarwal, George R. Brown, Alan J. Foubister, Lindsay J. Bawden, Gary Box, Alastair Donald, Elisabeth A. Bone, Sanjay R. Patel, Lindsay Stimson and Florence I. Raynaud and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

Andrew Belfield

8 papers receiving 331 citations

Peers

Countries citing papers authored by Andrew Belfield

Since Specialization

Citations

This map shows the geographic impact of Andrew Belfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Belfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Belfield more than expected).

Fields of papers citing papers by Andrew Belfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Belfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Belfield. The network helps show where Andrew Belfield may publish in the future.

Co-authorship network of co-authors of Andrew Belfield

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Belfield. A scholar is included among the top collaborators of Andrew Belfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Belfield. Andrew Belfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Co-learning in living labs: nurturing civic agency and resilience 2025 ·Buildings and Cities ·Andrew Belfield	0
2	Radical Urban Classrooms: Civic Pedagogies and Spaces of Learning on the Margins of Institutions 2024 ·Antipode ·(unknown), Andrew Belfield, (unknown)	1
3	Co-design, neighbourhood sharing, and commoning through urban living labs 2024 ·CoDesign ·Andrew Belfield, Doina Petrescu	3
4	Abstract 2677: JZP815, a potent and selective pan-RAF inhibitor, demonstrates efficacy in RAF and RAS mutant tumor pre-clinical models 2022 ·Cancer Research ·Robert Hauptschein, Simon A. Woodcock, Andrew Belfield, Helen Mason, (unknown), Svetlana V. Markova, Kyuri Kim, Shane Roller, (unknown), Clifford D. Jones, Robin Humphreys	1
5	Sharing and Space-Commoning Knowledge Through Urban Living Labs Across Different European Cities 2022 ·Urban Planning ·Doina Petrescu, (unknown), Carsten Keller, (unknown), Andrew Belfield, Florian Koch, (unknown), (unknown), (unknown)	4
6	Discovery of 2-(6-{[(6-Fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-N-hydroxypyrimidine-5-carboxamide (CHR-3996), a Class I Selective Orally Active Histone Deacetylase Inhibitor 2010 ·Journal of Medicinal Chemistry ·David Moffat, Sanjay R. Patel, (unknown), Andrew Belfield, Alastair Donald, Martin Rowlands, Judata I. Wibawa, Deborah H. Brotherton, Lindsay Stimson, Vanessa Clark, (unknown), Lindsay J. Bawden, Gary Box, Elisabeth A. Bone, Paul N. Mortenson, Anthea Hardcastle, (unknown), Suzanne A. Eccles, Florence I. Raynaud, Wynne Aherne	67
7	A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis 2004 ·Bioorganic & Medicinal Chemistry Letters ·Dearg S. Brown, Andrew Belfield, George R. Brown, Douglas S. Campbell, Alan J. Foubister, (unknown), Kurt G. Pike, (unknown), Stuart L. Wells	17
8	Catalytic Asymmetric Nazarov Reactions Promoted by Chiral Lewis Acid Complexes 2003 ·Organic Letters ·Varinder K. Aggarwal, Andrew Belfield	150
9	Recent synthetic advances in the nucleophilic amination of benzenes 1999 ·Tetrahedron ·Andrew Belfield, George R. Brown, Alan J. Foubister	71
10	Synthesis of Meta-substituted aniline derivatives by nucleophilic substitution 1999 ·Tetrahedron ·Andrew Belfield, George R. Brown, Alan J. Foubister, (unknown)	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact